Sanofi (NASDAQ:SNY) Shares Sold by Polar Asset Management Partners Inc.

Polar Asset Management Partners Inc. decreased its holdings in Sanofi (NASDAQ:SNY - Free Report) by 43.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,400 shares of the company's stock after selling 24,100 shares during the quarter. Polar Asset Management Partners Inc.'s holdings in Sanofi were worth $1,514,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of SNY. Synergy Asset Management LLC purchased a new stake in shares of Sanofi during the fourth quarter worth about $25,000. McClarren Financial Advisors Inc. increased its stake in Sanofi by 952.6% during the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company's stock worth $28,000 after buying an additional 543 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of Sanofi during the fourth quarter valued at approximately $31,000. Bessemer Group Inc. lifted its position in shares of Sanofi by 59.8% in the fourth quarter. Bessemer Group Inc. now owns 647 shares of the company's stock valued at $32,000 after acquiring an additional 242 shares in the last quarter. Finally, Sierra Ocean LLC purchased a new position in shares of Sanofi in the fourth quarter valued at approximately $44,000. Hedge funds and other institutional investors own 14.04% of the company's stock.

Analyst Ratings Changes

Several research analysts recently commented on the company. Sanford C. Bernstein raised Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. The Goldman Sachs Group assumed coverage on shares of Sanofi in a research note on Friday, March 21st. They issued a "neutral" rating and a $65.00 price target on the stock. Hsbc Global Res raised shares of Sanofi to a "strong-buy" rating in a research note on Monday, April 28th. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a "sell" rating to a "hold" rating in a report on Thursday, January 30th. Finally, BNP Paribas assumed coverage on Sanofi in a research note on Tuesday, April 15th. They set an "outperform" rating and a $65.00 price objective on the stock. Three research analysts have rated the stock with a hold rating, two have given a buy rating and three have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $63.33.

Sanofi Trading Up 0.7%

Shares of Sanofi stock traded up $0.36 during mid-day trading on Thursday, hitting $52.35. The stock had a trading volume of 2,236,487 shares, compared to its average volume of 2,382,764. The firm has a 50-day moving average of $52.45 and a two-hundred day moving average of $51.90. The firm has a market cap of $132.25 billion, a P/E ratio of 21.02, a price-to-earnings-growth ratio of 1.01 and a beta of 0.55. The company has a quick ratio of 1.14, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. Sanofi has a 12-month low of $45.80 and a 12-month high of $60.12.

Sanofi (NASDAQ:SNY - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.04. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. The company had revenue of $10.41 billion during the quarter, compared to analysts' expectations of $9.79 billion. During the same quarter last year, the firm earned $1.78 earnings per share. The firm's quarterly revenue was down 11.0% compared to the same quarter last year. Sell-side analysts forecast that Sanofi will post 4.36 earnings per share for the current year.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, June 12th. Shareholders of record on Friday, May 9th will be given a $2.0369 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a yield of 3.1%. This is a boost from Sanofi's previous annual dividend of $1.48. Sanofi's dividend payout ratio is presently 57.14%.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.